Gerresheimer AG (GRRMF)
29.05
0.00 (0.00%)
USD |
OTCM |
Oct 08, 16:00
Gerresheimer Net Income (Quarterly) : -126.36M for Feb. 28, 2026
Net Income (Quarterly) Chart
Historical Net Income (Quarterly) Data
| Date | Value |
|---|---|
| February 28, 2026 | -126.36M |
| November 30, 2025 | -357.13M |
| August 31, 2025 | -14.24M |
| May 31, 2025 | 19.57M |
| February 28, 2025 | -19.03M |
| November 30, 2024 | 41.66M |
| August 31, 2024 | 30.10M |
| May 31, 2024 | 35.57M |
| February 29, 2024 | 14.59M |
| November 30, 2023 | 45.17M |
| August 31, 2023 | 31.41M |
| May 31, 2023 | 38.57M |
| February 28, 2023 | 14.40M |
| November 30, 2022 | 34.66M |
| August 31, 2022 | 29.87M |
| May 31, 2022 | 28.86M |
| February 28, 2022 | 13.25M |
| November 30, 2021 | 32.92M |
| August 31, 2021 | 24.06M |
| May 31, 2021 | 34.66M |
| February 28, 2021 | 11.79M |
| November 30, 2020 | 36.02M |
| August 31, 2020 | 29.50M |
| May 31, 2020 | 32.27M |
| February 29, 2020 | 4.655M |
| Date | Value |
|---|---|
| November 30, 2019 | -91.42M |
| August 31, 2019 | 21.34M |
| May 31, 2019 | 52.96M |
| February 28, 2019 | 113.03M |
| November 30, 2018 | 50.22M |
| August 31, 2018 | 22.06M |
| May 31, 2018 | 23.37M |
| February 28, 2018 | 59.67M |
| November 30, 2017 | 45.35M |
| August 31, 2017 | 30.26M |
| May 31, 2017 | 27.14M |
| February 28, 2017 | 14.09M |
| November 30, 2016 | 26.26M |
| August 31, 2016 | 34.93M |
| May 31, 2016 | 32.57M |
| February 29, 2016 | 17.71M |
| November 30, 2015 | 63.57M |
| August 31, 2015 | 22.39M |
| May 31, 2015 | 24.44M |
| February 28, 2015 | 14.88M |
| November 30, 2014 | 27.74M |
| August 31, 2014 | 26.76M |
| May 31, 2014 | 28.73M |
| February 28, 2014 | 14.07M |
| November 30, 2013 | 35.73M |
Net Income Definition
Represents net income for the period and date(s) requested in local currency by default.
Net Income (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Net Income (Quarterly) Benchmarks
| Evotec SE | -54.24M |
| Lifecore Biomedical, Inc. | -6.156M |
| Repligen Corp. | 5.008M |
| Bio-Techne Corp. | 54.64M |
| Codexis, Inc. | -12.00M |
Net Income (Quarterly) Related Metrics
| Revenue (Quarterly) | 558.10M |
| Total Expenses (Quarterly) | 684.60M |
| EPS Diluted (Quarterly) | -3.345 |
| Enterprise Value | 3.440B |
| Gross Profit Margin (Quarterly) | 10.37% |
| Profit Margin (Quarterly) | -22.64% |
| Earnings Yield | -46.70% |
| Normalized Earnings Yield | -24.79 |